Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?

Del Mastro, L; Bighin, C; Bini, G; Giraudi, S; Taveggia, P; Levaggi, A; Canavese, G; Rescinito, G; Pronzato, P

Del Mastro, L; Bighin, C; Bini, G; Giraudi, S; Taveggia, P; Levaggi, A; Canavese, G; Rescinito, G; Pronzato, P.

Affiliation

Del Mastro L; Department of Medical Oncology. Electronic address: lucia.delmastro@istge.it.
Bighin C; Department of Medical Oncology.
Bini G; Department of Medical Oncology.
Giraudi S; Department of Medical Oncology.
Taveggia P; Department of Medical Oncology.
Levaggi A; Department of Medical Oncology.
Canavese G; Department of Surgical Oncology.
Rescinito G; Department of Radiology, National Cancer Research Institute, Genoa, Italy.
Pronzato P; Department of Medical Oncology.

Ann Oncol ; 21(6): 1376-1377, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20430904

Subject(s)

Anthracyclines/administration & dosage; Antibodies, Monoclonal/administration & dosage; Breast Neoplasms/drug therapy; Breast Neoplasms/surgery; Carcinoma, Ductal, Breast/drug therapy; Carcinoma, Ductal, Breast/surgery; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Breast Neoplasms/metabolism; Carcinoma, Ductal, Breast/metabolism; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Neoadjuvant Therapy/methods; Randomized Controlled Trials as Topic; Receptor, ErbB-2/metabolism; Trastuzumab

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Ductal, Breast / Anthracyclines / Antibodies, Monoclonal Type of study: Clinical_trials / Evaluation_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google